Abiopharma

Safe Pro Group Receives $780,000 Purchase Order for Department of War Package of Edge AI-Powered Threat Mapping and Blue UAS Drones

Zoetis - Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer

Compass Pathways - Compass Pathways to Participate in Canaccord Genuitys 46th Annual Growth Conference on August 12, 2026

Zoetis - Zoetis Announces Second Quarter 2026 Results

Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Sionna Therapeutics Reports Second Quarter 2026 Financial Results

Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Gilat Demonstrates Breakthrough AI-Based Interference Detection and Cancellation Technology for Satellite Links

KVH Industries Reports Second Quarter 2026 Results

Vistance Networks Board Approves Special Distribution

Daqo New Energy to Announce Unaudited Financial Results for the Second Quarter of 2026 on August 20, 2026

Zoetis Announces Second Quarter 2026 Results